Major side effects occur after coronary syndrome

Published Date: 13 Mar 2023

OSA itself predicted the incidence of MACCE in non-obese patients.

Read Full News

Latest News

CKM Syndrome Stages May Predict Risk for HF in Older Adults

Cardiovascular-kidney-metabolic syndrome staging may help identify which older adults are at greatest risk for incident heart failure.

Pandemic Linked to Rise in Youth Anxiety and Depression

Anxiety diagnoses rose in children and teens during the pandemic, especially in older teens.

Stroke and Embolism After Ablation for AF Patients

Stroke and systemic embolism occur at a low rate after catheter-based atrial ablation and may result in substantial sequelae or even death in certain cases.

AF Screening May Flag Increased HF Risk

Researchers quantify the risk for heart failure among people who screen positive for atrial fibrillation and suggest ECG could be warranted.

Graham Steell: Bedside Cardiology Before the ECG

In an era without ECG or routine x ray, Graham Steell linked heart sounds and pulse tracings to pathology, showing how careful bedside observation can still shape diagnosis.

Culture-Negative Endocarditis Shows Distinct Patterns

Patients with culture-negative infective endocarditis differ in presentation and features of the disease from those with culture-positive infective endocarditis but have similar survival outcomes.

Todays Updates

Episode 2: Diagnosing and Managing Cushing Syndrome

Drs Marwah Abdalla and Lewis Blevins discuss Cushing syndrome: Why it is frequently missed, how clinicians can screen for it, and how to manage it.

MASLD for Cardiologists

An overview of MASLD, including the epidemiology, diagnostic approaches, and therapeutic options highlighting the cardiologists’ role in its multidisciplinary management.

Jan 30 2026 This Week in Cardiology

Listener feedback, huge news in the rapidly expanding world of PFA AF Ablation, obesity, and a beautiful trial studying an AI-enhanced diagnostic tool in the office are the topics discussed by John Mandrola, MD, in this week’s podcast.

Exogenous Ketones and Exercise Tolerance: KETO-HFpEF

A crossover trial to determine whether ketone ester improves exercise tolerance in HFpEF.

Feb 06 2026 This Week in Cardiology

Problems with the PREVENT score, a breakthrough in lipid-lowering therapy, a surprising benefit in stroke care, and more thoughts on statins and preventive care of heart disease are the topics John Mandrola, MD, discusses in this week’s podcast.

Frailty in CVD: Time for a Universal Definition!

Citing The Death of Ivan Ilyich, the authors call for professional societies to jointly embrace a core definition of frailty for cardiovascular care and clinical practice.

Immunotherapy Combo Shows Promise for Hodgkin Lymphoma

A phase 2 study evaluates the safety and efficacy of brentuximab vedotin and nivolumab plus chemotherapy in patients with early-stage classical Hodgkin lymphoma.

Todays Updates

Episode 2: Diagnosing and Managing Cushing Syndrome

Drs Marwah Abdalla and Lewis Blevins discuss Cushing syndrome: Why it is frequently missed, how clinicians can screen for it, and how to manage it.

MASLD for Cardiologists

An overview of MASLD, including the epidemiology, diagnostic approaches, and therapeutic options highlighting the cardiologists’ role in its multidisciplinary management.

Jan 30 2026 This Week in Cardiology

Listener feedback, huge news in the rapidly expanding world of PFA AF Ablation, obesity, and a beautiful trial studying an AI-enhanced diagnostic tool in the office are the topics discussed by John Mandrola, MD, in this week’s podcast.

Exogenous Ketones and Exercise Tolerance: KETO-HFpEF

A crossover trial to determine whether ketone ester improves exercise tolerance in HFpEF.

Feb 06 2026 This Week in Cardiology

Problems with the PREVENT score, a breakthrough in lipid-lowering therapy, a surprising benefit in stroke care, and more thoughts on statins and preventive care of heart disease are the topics John Mandrola, MD, discusses in this week’s podcast.

Frailty in CVD: Time for a Universal Definition!

Citing The Death of Ivan Ilyich, the authors call for professional societies to jointly embrace a core definition of frailty for cardiovascular care and clinical practice.

Immunotherapy Combo Shows Promise for Hodgkin Lymphoma

A phase 2 study evaluates the safety and efficacy of brentuximab vedotin and nivolumab plus chemotherapy in patients with early-stage classical Hodgkin lymphoma.

Latest News

Cardiovascular-kidney-metabolic syndrome staging may help identify which older adults are at greatest risk for incident heart failure.

Anxiety diagnoses rose in children and teens during the pandemic, especially in older teens.

Stroke and systemic embolism occur at a low rate after catheter-based atrial ablation and may result in substantial sequelae or even death in certain cases.

Researchers quantify the risk for heart failure among people who screen positive for atrial fibrillation and suggest ECG could be warranted.

In an era without ECG or routine x ray, Graham Steell linked heart sounds and pulse tracings to pathology, showing how careful bedside observation can still shape diagnosis.

Patients with culture-negative infective endocarditis differ in presentation and features of the disease from those with culture-positive infective endocarditis but have similar survival outcomes.

News All Time

Tirzepatide Bests Semaglutide in 12-Month Real-World Study

Tirzepatide is associated with a greater mean percent body weight reduction than semaglutide in adults with obesity or overweight and one or more related complications.

Long COVID May Increase Your Heart Disease Risk

Individuals with long COVID face a substantially higher risk of developing cardiovascular disease — particularly cardiac arrhythmias and coronary artery disease — than those without long COVID.

MHRA Approves Olezarsen for Rare Lipid Disorder

The MHRA has approved olezarsen for familial chylomicronaemia syndrome, a rare disorder linked to life-threatening pancreatitis.

BP Lower Than Target in Many With Coronary Heart Disease

Over one third of patients with coronary heart disease have blood pressure below targets recommended by European guidelines and have elevated risks for heart and kidney diseases.

Lower LDL-C Target May Improve CV Outcomes

A study finds direct evidence to support guideline changes that promote lower targets for low-density lipoprotein cholesterol.

Can Remote Pressure Monitoring Lower HF Hospitalisation?

A wireless implantable device that remotely monitors pulmonary artery pressure offers reliable safety and is linked to a significant reduction in the risk for heart failure-related hospitalisation.

Does Pregnancy Loss Signal Future Heart Disease?

A history of stillbirth or miscarriage is linked to an increased risk for cardiovascular disease in women.

Surgery Benefits Heart Health in Mild Cortisol Excess

In patients with mild autonomous cortisol secretion, adrenalectomy provides comprehensive cardiovascular benefits, improving blood pressure, cardiac structure, and coagulation profile.

Exercise Intensity Over Volume Linked to Lower Disease Risks

Higher intensity of physical activity, regardless of total volume, is linked to significantly lower risks for many cardiovascular and other chronic diseases and death.

Genetic Risk Tied to Postpartum BP Risk, BMI Matters More

First-time mothers with high genetic risk for systolic blood pressure have a higher likelihood of postpartum hypertension, but BMI and hypertensive pregnancy disorders are stronger risk factors.

The Case for Muscle Power Over Strength

The ability to move a weight with force may be a better predictor of mortality risk than how much weight you can move overall. A beneficial tweak for exercise Rx?

AI Model Can Help Cut Hospitalizations in Dialysis Patients

AI-driven interventions reduce the odds of hospitalization within 7 days by 8% in patients with end-stage kidney disease receiving hemodialysis, according to a recent study.

Apixaban May Cut Stroke Risk but Raise Bleeding in Dialysis

Observational data suggest apixaban leads to fewer thromboembolic events but higher bleeding risk, highlighting the need for individualized decision-making in dialysis patients.

Wall Thickness Heterogeneity Improves Cardiomyopathy Detection

Heterogeneity in the thickness of the heart wall, represented by wall thickness standard deviation, can improve the early detection of hypertrophic cardiomyopathy and mutation carriers, a study shows.

Veterans Often Miss Out on Quadruple Therapy for HFrEF

Most US veterans who have new heart failure with reduced ejection fraction do not receive all four classes of guideline-directed medical therapy, and many die before starting full therapy, a study finds.

Empagliflozin May Boost Exercise Tolerance in T2D

In patients with type 2 diabetes, 6 months of empagliflozin therapy vs sitagliptin therapy is tied to a modest increase in the fat oxidation rate during exercise of low-to-moderate intensity.

Recommended News For You

Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.

Healthy weight loss could lower your odds for cancer

X-ray and radar technology combined to reduce cancer screening risks

Mortality up for children with leukemia from lowest SES neighborhoods

United States Lung Cancer Screening Rates Remain Low. s. in particular in the South.

Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer

Top Cancer Centers; Phase III Win in Prostate Cancer; Screening Recs for Anal Cancer

Recommended Articles For You

Exploring the Latest Advances in Hodgkin's Lymphoma Treatment 

Can AI Become Our Oncologic Ally? A Look at Artificial Intelligence in Cancer Detection and Control 

Advancements in Breast Cancer Treatment: From Chemotherapy to Immunotherapy 

Understanding Lymphedema: Symptoms, Causes, and Treatment  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA-approved FGFR inhibitors show promise against rare and aggressive pediatric brain tumor

2.

Sickle Cell Disease Drug Pulled From Global Markets

3.

A US health panel advises starting mammograms at age 40 rather than 50.

4.

'Converging' Evidence of Link Between Air Pollution and Breast Cancer

5.

Getting More Done With Less Blood.

1.

Cancer Immunotherapy: Advances, Guidelines, and Practical Tools for Modern Oncology Practice

2.

The Silent Danger of Hematoma: How to Identify and Treat This Potentially Serious Condition

3.

Exploring the Use of Bevacizumab in Treating Different Types of Cancers 

4.

Unlocking the Potential of Palbociclib: A Comprehensive Overview

5.

Unveiling New Hope: Potential Therapeutic Targets in Hematological Malignancies

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

2.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

3.

Current Scenario of Cancer- The Incidence of Cancer in Men

4.

Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot